U.S., Oct. 29 -- An application to own the trademark for 'D-FI' has been filed on May. 13, 2025.
Owner(s):
Castle Creek Biosciences, LLC; 405 Eagleview Boulevard, , PENNSYLVANIA
Goods and/or Services:
For: gene therapy products, namely, genetically modified cells for medical use for the treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and injectable biological preparations containing genetically modified materials for treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and therapeutic preparations for treatment of skin diseases, connective tissue diseases, arthritis and autoimmune diseases
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https...